Related Articles
Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway
Gene expression markers in circulating tumor cells may predict bone metastasis and response to hormonal treatment in breast cancer
miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1
P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells
Eckol inhibits Reg3A‑induced proliferation of human SW1990 pancreatic cancer cells